Background: referral for echocardiography for all geriatric outpatients suspected of heart failure (HF) is not feasible. Diagnostic algorithms could be helpful. Objective: to investigate whether available diagnostic algorithms accurately identify (older) patients (aged 70 years or over) eligible for echocardiography, with acceptable numbers of false-negatives. Methods: algorithms (European Society of Cardiology (ESC)) guideline, National Institute for Health and Clinical Excellence (NICE) guideline, multidisciplinary guideline the Netherlands (NL) and algorithm by Mant et al. were validated in 203 geriatric patients (mean age 82 ± 6 years, 30% men) suspected of new, slow onset HF. HF was adjudicated by an outcome panel. Applicability of algorithms was evaluated by calculating proportion of patients (i) referred for echocardiography, (ii) with HF among referred patients and (iii) without HF in the non-referred. Results: ninety-two (45%) patients had HF. Applying algorithms resulted in referral for echocardiography in 52% (normal NT-proBNP; ESC), 72% (normal ECG; ESC), 56% (NICE), 93% (NL) and 70% (Mant) of all patients, diagnosing HF in 78, 56, 76, 49 and 62% of those referred, respectively. In patients not referred for echocardiography HF was absent in 90, 82, 93, 100 and 95%, respectively. Conclusion: the ESC NT-proBNP (<400 pg/ml)-based algorithm combines the lowest number of referrals for echocardiography (of whom 78% has HF) with a limited number (10%) of false negatives in the non-referred.
Introduction
Ageing of the population and improved survival following acute cardiac events has led to an increased prevalence of heart failure (HF), especially in the elderly [1, 2] . Diagnosing HF is important for patient management, because of beneficial effects on both morbidity and mortality of targeted interventions [3] [4] [5] . Unfortunately, detecting HF in the elderly with a wide range of comorbidity is notoriously difficult, particularly in the early stages and in a setting without direct access to echocardiography, such as in primary care or geriatric practice [6] . Clinicians, other than cardiologists, do not routinely use echocardiography in the diagnostic work-up of HF [7] . Natriuretic peptides are increasingly used in the diagnostic assessment of HF. Although serum levels of natriuretic peptides rise with age [8, 9] , specific cut-off values to rule out the presence of HF are not available for elderly patients suspected of new, slow onset HF. Diagnostic algorithms can support clinicians in the evaluation of patients suspected of HF. Available algorithms are generally aimed at excluding HF and identifying patients who require referral for additional diagnostic investigations (in particular echocardiography) to establish the presence and cause of HF. The latter will guide treatment [3] . Unfortunately, these algorithms are generally derived and validated in populations that include few elderly patients. We set out to assess the applicability of existing diagnostic algorithms to geriatric outpatients (aged 70 years or over) suspected of new, slow onset HF.
Methods Search
In December 2010, the MEDLINE database was searched for publications on diagnostic algorithms to diagnose new, slow onset HF (see Supplementary data are available in Age and Ageing online, Appendix). To identify relevant publications missed by the search, reference lists of all manuscripts identified and those of relevant review articles were scrutinised. Only algorithms based on diagnostic tests available to geriatricians (thus excluding echocardiography) were included and the diagnosis of HF should have been based on an adequate reference ('gold') standard (i.e. clinical or echocardiographic evaluation). Only the latest versions of the algorithms were included.
Validation sample
The validation sample consisted of patients aged 70 years or older referred for a variety of reasons to the geriatric outpatient clinic of two regional hospitals in the Netherlands (Elkerliek Hospital, Helmond and Meander Medical Center, Amersfoort). When the geriatrician had a suspicion of HF because of breathlessness, fatigue, ankle swelling or any combination of these, patients were eligible for this study as detailed previously [10] . Patients were excluded when ankle swelling was the single sign present and was evidently caused by venous insufficiency, emergency admission for HF was needed or when a diagnosis of HF had already been established by a cardiologist. Participants underwent a standardised diagnostic work-up (including clinical history, physical examination, chest X-ray, electrocardiography (ECG), laboratory tests and echocardiography). None of the patients had previously undergone echocardiography. Information on comorbidity was obtained from the general practitioner's referral letter and letters of other specialists retrieved from the hospital information system. Diagnoses established by the geriatricians during a complete geriatric assessment and within 2 months after the initial visit were used to complete information on comorbidity. An outcome panel consisting of a cardiologist, general practitioner, pulmonologist and geriatrician established the presence or absence of HF according to the prevailing diagnostic criteria for HF of the European Society of Cardiology (ESC) [11] , using all available diagnostic information including N-terminal pro-B-type natriuretic peptide (NT-proBNP), echocardiography and clinical course (e.g. response to therapy) during a 6-month followup period. HF was considered present when symptoms and signs suggestive of HF (such as breathlessness, ankle swelling, fatigue, pulmonary rales and elevated jugular venous pressure) were present combined with objective echocardiographic evidence of cardiac dysfunction at rest. Patients with HF were further classified as having systolic HF (left ventricular ejection fraction (LVEF) less than 45%), and HF with preserved ejection fraction (HFPEF; echocardiographic evidence of diastolic dysfunction (abnormal left ventricular relaxation or diastolic stiffness) in combination with LVEF ≥45%). To prevent incorporation bias, which is an important issue in this type of diagnostic research [12] , NT-proBNP values were only provided to the outcome panel, after the presence or absence of HF had been established based on all other diagnostic information (including echocardiography). Only in three (1%) patients' knowledge of NT-proBNP values led to reconsideration of the initial diagnosis.
All participants or their representatives, in case of impaired cognition, gave written consent. The inclusion started July 2003 and ended July 2007. The study was approved by the Medical Ethical Committees of both participating hospitals.
Data analysis
Univariate analyses were performed using t-tests for continuous variables and χ 2 tests for differences in proportions. The diagnostic algorithms were evaluated by applying the algorithms to each patient in the validation sample and comparing the results to the observed outcome, i.e. whether the patient actually had HF according to the outcome panel. Applicability of diagnostic algorithms was evaluated by calculating the following measures: (i) proportion of suspected patients in whom the algorithm recommends referral for echocardiography (% referred patients), (ii) proportion of patients in whom the algorithm recommends referral for echocardiography, which indeed has HF ( positive-predictive value) and (iii) proportion of patients in whom HF is excluded according to the algorithm, that indeed does not have HF (negative-predictive values) Predictive values were presented with 95% confidence intervals.
Overall, the number of missing variables was less than 1% (range: 0-2%). Prior to analysis we imputed values by using a regression method [13] . Data were analysed using the SPSS software (version 17.0 for Windows SPSS, Inc., Chicago, IL, USA).
Results

Algorithms
The MEDLINE search identified four algorithms to potentially apply to geriatric outpatients suspected of new, slow onset HF ( Figure 1 ): algorithms from the 'Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008' of the ESC; from 'Chronic Heart Failure, National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care' of the National Institute for Health and Clinical Excellence (NICE), UK; from the 'Multidisciplinary Guidelines for Heart Failure 2010', The Netherlands (NL) and from the study performed by Mant et al. [3, [14] [15] [16] .
Mant performed a systematic review of the diagnosis of HF based on clinical features and investigations available in a primary care setting [15] . The prediction rule was developed in the data set of the United Kingdom Natriuretic Peptide (UKNP) study of Zaphiriou et al. [17] , which confirmed the ability of natriuretic peptides to 'rule-out' HF in 306 patients (104 (34%) with HF) suspected of HF by their general practitioner [17] . The prediction rule was externally validated in five other data sets, and converted to an algorithm.
Validation
The mean age of the 203 geriatric patients in the validation sample was 82 years (range: 70-98 years), 30% were male, and according to the outcome panel, new, slow onset HF was present in 92 (45%) patients (Table 1 ). The main reasons for referral were functional impairment (39%), breathlessness (35%), cognitive impairment (31%) and mobility disorders (29%). Forty-nine (53%) patients had 'systolic' HF (median LVEF 35% (inter-quartile range (IQR) 27.5-40.0)) and 39 (42%) had HFPEF (median LVEF 50% (IQR: 45-60)). In four patients, left ventricular function was normal but HF was present due to right-sided HF (two patients), severe mitral regurgitation (one patient) and aortic stenosis (one patient). Patients with HF were older (83 and 81 years, respectively; P = 0.01), more often male (37 and 24%; P = 0.05) and more frequently had a history of myocardial infarction (18 and 5%; P = 0.003) and atrial fibrillation (39 and 5%; P < 0.001) compared with patients without HF. The mean number of drugs used per patient was six.
Other than HF, the most common diagnoses newly established by the geriatricians were cognitive disorders (23 and 30%, P = 0.27), vitamin deficiency (23 and 20%, P = 0.60), orthostatic hypotension (14 and 18%, P = 0.46), mood disorders (14 and 16%, P = 0.68) and chronic obstructive pulmonary disease (COPD; 12 and 14%, P = 0.74) in patient's with and without HF, respectively.
The results of applying the diagnostic algorithms to the geriatric validation sample are provided in Table 2 . Thresholds below which the prevalence of HF was less than 20% were chosen in the diagnostic algorithm of Mant. Applying the diagnostic algorithms resulted in referral for echocardiography in 52% (normal NT-proBNP; ESC), 72% (normal ECG; ESC), 56% (NICE), 93% (NL) and 
Discussion
Available diagnostic algorithms (ESC, NICE, NL and Mant) reliably exclude the presence of HF in elderly outpatients suspected of new, slow onset HF by their geriatrician. The prevalence of HF in patients not referred for additional investigations, notably echocardiography, ranges from 0 to 18%. Strict application of these algorithms, however, also leads to a significant proportion (range: 52-93%) of patients undergoing further evaluation, in particular echocardiography.
The validation sample consisted of elderly patients (mean age 82 years, 70% women) with a wide range of both cardiovascular and non-cardiovascular comorbidity (e. g. hypertension, atrial fibrillation, COPD, cognitive disorders), using an average of six medications, who were suspected of new, slow onset HF by their geriatrician because of the presence of symptoms and signs suggestive of HF. The prevalence of HF (45%) was in line with findings from earlier studies [8, 9] . Although none of the participants had a prior diagnosis of HF, in one-third a loop diuretic was prescribed. Loop diuretics are commonly used as part of antihypertensive treatment in the Netherlands (although thiazide diuretics are recommended) and loop diuretics are also known to be prescribed in patients with ankle swelling or dyspnoea without first confirming or excluding the presence of HF [18] .
The ESC NT-proBNP (<400 pg/ml)-based algorithm combines the lowest number of referrals for echocardiography (of whom 78% has HF) with a limited number (10%) of false negatives in the non-referred. Although earlier studies showed that NT-proBNP safely excluded the presence of HF in primary care patients and nursing home residents [19, 20] at first sight, the finding that an algorithm that merely uses NT-proBNP (ESC) performs better than algorithms that combine NT-proBNP and clinical variables may come as a surprise. It is, however, known that classic features of HF may have limited value in geriatric patients: pulmonary rales and oedema are frequently present even in the absence of cardiac dysfunction [21] . The algorithm of Mant contains both items ( pulmonary rales and oedema) explaining at least partially its limited use in excluding HF in this geriatric cohort. Adding the presence of a previous myocardial infarction to the 400 pg/ml NT-proBNP cut-off value, as done in the algorithm of the NICE guideline, did not lead to more adequate referrals or less false negatives compared with the ESC NT-proBNP-based algorithm. The algorithm of the Dutch multidisciplinary guideline, combining a normal ECG with a NT-proBNP level below 125 pg/ml, may be useful to exclude HF in general practice, but results in a 93% referral rate in geriatric patients suspected of HF. Similarly, combining a normal ECG with NT-proBNP levels below 400 pg/ml (as (8) 10 (11) 7 (6) Data are presented as mean ± SD, median (inter-quartile range: 25-75 th percentiles), or number (%) of patients. ACE-i, angiotensin-converting enzyme inhibitor; ARBs, angiotensin II receptor blockers; COPD, chronic obstructive pulmonary disease; CVA, cerebro vascular accident; HF, heart failure; Ischaemic heart disease includes prior myocardial infarction, angina pectoris, coronary artery bypass grafting and percutaneous coronary intervention; NT-proBNP, N-terminal pro-B-type natriuretic peptide; TIA, transient ischaemic attack; vascular comorbidity includes hypertension, diabetes mellitus, stroke and peripheral artery disease. Information on comorbidities was obtained from the general practitioner's referral letter and letters of other specialists retrieved from the hospital information system. Diagnoses established by the geriatricians during a complete geriatric assessment and within 2 months after the initial visit were used to complete information on comorbidity.
suggested by the ESC) would have resulted in a high referral rate as well: 160 (79%) patients would have to undergo echocardiography (87 (54%) patients having HF; data not shown) with HF being absent in 38 (88%) of the 43 nonreferred patients. Thus, adding a normal ECG to various NT-proBNP cut-off levels does not improve diagnostic accuracy in geriatric patients. This is probably due to the limited amount of patients without HF that have a normal ECG in our geriatric cohort (59% of patients without HF). The ESC guideline also states that the presence of HF is likely when NT-proBNP levels exceed 2000 pg/ml, mandating referral for echocardiography. Fifty patients (25%) of our geriatric cohort had NT-proBNP values above 2000 pg/ml, with only one of them ultimately being diagnosed as not having HF ( positive-predictive value 98%). Our findings indicate that in geriatric patients suspected of new, slow onset HF NT-proBNP values below 400 pg/ml safely exclude HF (HF treatment can be withheld), whereas NT-proBNP values higher than 2000 pg/ml adequately confirm the presence of HF, and (symptomatic) treatment should be started. In the remaining patients (n = 55, 27%) with equivocal NT-proBNP values (400-2000 pg/ml), uncertainty about the presence or absence of HF could lead to a strategy of watchful waiting, and initiation of treatment if symptoms worsen. Unfortunately, accessibility of natriuretic peptides may be limited [22] , complicating implementation of the studied algorithms.
In patients in whom algorithms incorrectly concluded HF to be absent (false negatives), the proportion of patients with systolic HF (left ventricular ejection fraction < 45%) and HFPEF (diastolic dysfunction in combination with left ventricular ejection fraction ≥ 45%) was the same (data not shown). Physicians will always consider the tradeoff between the yield of additional investigations and the burden these investigations impose on their patients. Echocardiography, key to determine the presence and cause of HF, is generally considered a patient friendly, easy to perform test that has no side effects. Nevertheless, for elderly patients, who are likely to have multiple comorbidities [23, 24] , a hospital visit to undergo echocardiography is a considerable effort. Current daily practice shows that performing echocardiography in all patients suspected of HF by non-cardiologists is a non-realistic option [7] . In geriatric practice, the aim of medical care is to improve the quality of life by reducing symptoms, rather than merely improving survival. As such, the management of HF in geriatric patients will generally consist of lifestyle advice and medications. The proportion of patients receiving more advanced treatment for HF, e.g. device therapy, percutaneous interventions or open heart surgery, is negligible [25, 26] . It follows that there is a need for strategies to reliably rule in or out the presence of HF in this specific patient group, using easily obtainable information from medical history, physical examination, electrocardiography and laboratory testing (such as natriuretic peptides) and reserving additional investigations only for those in whom the presence of HF remains uncertain or for the few geriatric patients who may benefit from advanced treatment options (e.g. valve replacement). Handheld echocardiography may lower the threshold to perform echocardiography in the near future, but we are not aware of studies assessing the cost-effectiveness of these devices in elderly patients suspected of HF.
Management of HF in elderly patients with a wide range of comorbidities is complicated by the lack of evidencebased guidance as they are often excluded from participation in trials [27, 28] . No therapeutic interventions have been proved to improve the outcome in HFPEF, which is present in half of the elderly patients with HF [29] . The therapeutic management of elderly patients with systolic HF is largely based on extrapolating findings from studies performed in younger patients with less comorbidity [27] . This said, a few studies performed in elderly patients, show benefit of betablockers [4] and angiotensin-converting enzyme (ACE) inhibitors [5] . Despite the scarcity of evidence for treatment benefits, establishing a correct diagnosis in elderly patients with a wide range of comorbidities remains essential, not only for those who are found to have HF, but also to prevent potential side effects in those not having HF.
The present study, the largest in geriatric patients suspected of new, slow onset HF to date, provides information Figure 1D ).
on a specific group of patients largely ignored in previous (diagnostic) HF studies. Another strength of our study is that, to reflect daily practice, only algorithms using diagnostic tests generally available to geriatricians were included. Limitations, inherent to the nature of our diagnostic study, need to be discussed. Establishing the diagnosis HF is difficult because a gold standard is lacking. This mandated the use of an outcome panel to attribute a final diagnosis of HF, of which the consensus diagnosis was highly reproducible, as in previous studies [30, 31] . The introduction of natriuretic peptides has revolutionised the assessment of HF [3, 30] , but limited information is available regarding reference values in elderly patients. The first study to derive NT-proBNP reference values for HF in patients aged 70 years and older was performed in patients with acute onset of HF [8] . Levels of natriuretic peptides will be lower in the type of patients included in our study, i.e. those with slow onset HF [17, 30] . The 2005 ESC HF guidelines [11] , used by the outcome panel to diagnose the presence or absence of HF in the validation sample, did not specify NT-proBNP cut-off values. In combination with the absence of reference values for elderly patients with slow onset HF, this meant that echocardiography was of primary importance in the final diagnosis of HF by the outcome panel in our study.
Conclusions
Existing diagnostic algorithms accurately rule out HF in geriatric outpatients suspected of new, slow onset HF by their geriatrician. Unfortunately these algorithms refer a significant amount (52-93%) of patients for additional investigations, notably echocardiography. The NT-proBNP-based ESC algorithm appears to be the current algorithm of choice for geriatric outpatients, combining the lowest number of referrals (52%) for echocardiography (of whom the majority has HF) with a few false negatives (10%) in the non-referred. There remains a need for better diagnostic algorithms in geriatric patients suspected of HF that combine low false negative rates with fewer referrals for echocardiography.
Key points
• Diagnosing slow onset HF in geriatric patients is difficult without direct access to echocardiography • Four diagnostic algorithms were identified to help ruling out HF or limiting the number of patients needing echocardiography • The ESC NT-proBNP (<400 pg/ml)-based algorithm referred the least number of patients for echocardiography (of whom 78% has HF) • This algorithm had a limited number (10%) of false negatives in the non-referred
